Get the Stockscreener App
14.60
4.82%
-0.74
Pre-market:
15.15
0.55
+3.77%
Lensar Inc stock is traded at $14.60, with a volume of 117.53K.
It is down -4.82% in the last 24 hours and up +33.94% over the past month.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.
See More
Previous Close:
$15.34
Open:
$15.27
24h Volume:
117.53K
Relative Volume:
1.27
Market Cap:
$172.13M
Revenue:
$42.16M
Net Income/Loss:
$-14.38M
P/E Ratio:
-8.1564
EPS:
-1.79
Net Cash Flow:
$-9.90M
1W Performance:
+6.80%
1M Performance:
+33.94%
6M Performance:
+188.54%
1Y Performance:
+250.96%
1-Day Range:
$14.50
$15.90
1-Week Range:
$12.71
$15.90
52-Week Range:
$2.67
$16.40
Lensar Inc Stock (LNSR) Company Profile
Name
Lensar Inc
Sector
Industry
Phone
888-536-7271
Address
2800 DISCOVERY DRIVE, ORLANDO
Compare LNSR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LNSR
Lensar Inc
|
14.60 | 172.13M | 42.16M | -14.38M | -9.90M | -1.79 |
|
ABT
Abbott Laboratories
|
129.89 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.37 | 140.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
363.66 | 138.77B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
92.33 | 118.39B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
67.95 | 39.95B | 5.72B | 4.17B | 259.90M | 6.97 |
Lensar Inc Stock (LNSR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-24-21 | Initiated | SVB Leerink | Outperform |
Lensar Inc Stock (LNSR) Latest News
LENSARTop Healthcare Equipment Stock - Inkl
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
LENSAR announces inducement grants - Medical Buyer
Lensar Inc. Reports Record Revenue and Optimistic Outlook - TipRanks
LENSAR Awards New Hires Stock Options at $13.48What This Means for Shareholders - StockTitan
LENSAR, Inc. (NASDAQ:LNSR) Q4 2024 Earnings Call Transcript - Insider Monkey
LENSAR (NASDAQ:LNSR) Price Target Raised to $16.00 - Defense World
LENSAR revenue jumps 38% to USD 16.7M in Q4 2024 - Medical Buyer
LENSAR (NASDAQ:LNSR) Announces Quarterly Earnings Results - MarketBeat
LENSAR Inc (LNSR) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Market ... - Yahoo Finance
LENSAR, Inc. Reports Strong 2024 Financial Performance - TipRanks
LENSAR, Inc. SEC 10-K Report - TradingView
LENSAR Inc Q4 2024 Earnings: Revenue Surges to $16.7M, Beating E - GuruFocus.com
LENSAR stock surges 23.7% as Q4 revenue beats estimates - Investing.com India
LENSAR Inc reports results for the quarter ended December 31Earnings Summary - TradingView
LENSAR stock surges 23.7% as Q4 revenue beats estimates By Investing.com - Investing.com Canada
LENSAR Stock Soars to 52-Week High, Hits $12.19 Amid Growth By Investing.com - Investing.com South Africa
LENSAR Stock Soars to 52-Week High, Hits $12.19 Amid Growth - Investing.com
Earnings call transcript: LENSAR Q4 2024 misses EPS, beats revenue By Investing.com - Investing.com South Africa
Earnings call transcript: LENSAR Q4 2024 misses EPS, beats revenue - Investing.com
LENSAR Earnings Results: $LNSR Reports Quarterly Earnings - Nasdaq
LENSAR Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update - TradingView
LENSAR Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update - GlobeNewswire Inc.
Earnings To Watch: LENSAR Inc (LNSR) Reports Q4 2024 Result - GuruFocus.com
LENSAR Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView
Institutions along with individual investors who hold considerable shares inLENSAR, Inc. (NASDAQ:LNSR) come under pressure; lose 12% of holdings value - Simply Wall St
Trend Tracker for (LNSR) - Stock Traders Daily
LENSAR (LNSR) Expected to Announce Earnings on Thursday - MarketBeat
LENSAR, Inc. to Release Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 - Nasdaq
LENSAR to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 27, 2025 - GlobeNewswire
When Will LENSAR Reveal Its Latest Financials? Key Date for Medical Tech Investors - StockTitan
How to Take Advantage of moves in (LNSR) - Stock Traders Daily
Navigating the Volatility of LENSAR Inc’s (LNSR) Stock - The News Heater
Medical Devices Firm Lensar Surges Ahead On Robotic Technology (NASDAQ:LNSR) - Seeking Alpha
LENSAR reports inducement grants - Medical Buyer
LENSAR Awards Strategic Employee Stock Options: Key Details Revealed - StockTitan
(LNSR) On The My Stocks Page - Stock Traders Daily
Even With A 28% Surge, Cautious Investors Are Not Rewarding LENSAR, Inc.'s (NASDAQ:LNSR) Performance Completely - Simply Wall St
LENSAR, Inc.'s (NASDAQ:LNSR) Profit Outlook - Simply Wall St
LENSAR, Inc. (NASDAQ:LNSR) surges 13%; retail investors who own 40% shares profited along with institutions - Yahoo Finance
LENSAR Stock Soars to 52-Week High, Reaching $9.25 - MSN
LENSAR Stock Soars to 52-Week High, Reaching $9.25 By Investing.com - Investing.com South Africa
(LNSR) Investment Analysis - Stock Traders Daily
Geode Capital Management LLC Raises Position in LENSAR, Inc. (NASDAQ:LNSR) - Defense World
Trading (LNSR) With Integrated Risk Controls - Stock Traders Daily
Paradigm Medical Industries (OTCMKTS:PDMI) vs. LENSAR (NASDAQ:LNSR) Head-To-Head Analysis - Defense World
Lensar Inc Stock (LNSR) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.40%
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):